Bergmann, C., Distler, J. H. W., Treutlein, C., Tascilar, K., Müller, A., Atzinger, A., . . . Schmidkonz, C. (2021). 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: A single-centre, pilot study. The Lancet Rheumatology, 3(3), e185. https://doi.org/10.1016/S2665-9913(20)30421-5

Bergmann, Christina, et al. "68Ga-FAPI-04 PET-CT for Molecular Assessment of Fibroblast Activation and Risk Evaluation in Systemic Sclerosis-associated Interstitial Lung Disease: A Single-centre, Pilot Study." The Lancet Rheumatology 3, no. 3 (2021): e185. https://doi.org/10.1016/S2665-9913(20)30421-5.

Bergmann, Christina, et al. "68Ga-FAPI-04 PET-CT for Molecular Assessment of Fibroblast Activation and Risk Evaluation in Systemic Sclerosis-associated Interstitial Lung Disease: A Single-centre, Pilot Study." The Lancet Rheumatology, vol. 3, no. 3, 2021, p. e185, https://doi.org/10.1016/S2665-9913(20)30421-5.